Guanidinylated neomycin mediates heparan sulfate-dependent transport of active enzymes to lysosomes

30Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Guanidinylated neomycin (GNeo) can transport bioactive, high molecular weight cargo into the interior of cells in a process that depends on cell surface heparan sulfate proteoglycans. In this report, we show that GNeo-modified quantum dots bind to cell surface heparan sulfate, undergo endocytosis and eventually reach the lysosomal compartment. An N-hydroxysuccinimide activated ester of GNeo (GNeo-NHS) was prepared and conjugated to two lysosomal enzymes, Β-D-glucuronidase (GUS) and α-L-iduronidase. Conjugation did not interfere with enzyme activity and enabled binding of the enzymes to heparin-Sepharose and heparan sulfate on primary human fibroblasts. Cells lacking the corresponding lysosomal enzyme took up sufficient amounts of the conjugated enzymes to restore normal turnover of glycosaminoglycans. The high capacity of proteoglycan-mediated uptake suggests that this method of delivery might be used for enzyme replacement or introduction of foreign enzymes into cells. © The American Society of Gene & Cell Therapy.

Cite

CITATION STYLE

APA

Sarrazin, S., Wilson, B., Sly, W. S., Tor, Y., & Esko, J. D. (2010). Guanidinylated neomycin mediates heparan sulfate-dependent transport of active enzymes to lysosomes. Molecular Therapy, 18(7), 1268–1274. https://doi.org/10.1038/mt.2010.78

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free